Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,115,230
+$9,826 QoQ
Shares Held
36,710
+5.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#810
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. BMY ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
|
10,410 | $1,631,455 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,115,230 | 36,710 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,105,404 | 34,714 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,719,121 | 31,871 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,436,705 | 31,856 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,855,210 | 40,078 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,591,587 | 42,492 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,419,071 | 42,770 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,102,817 | 40,642 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,616,845 | 38,932 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,408,679 | 44,416 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,269,543 | 44,232 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,502,075 | 25,880 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,712,772 | 26,783 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,907,203 | 27,517 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,979,776 | 27,516 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,957,178 | 27,531 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,119,810 | 27,530 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,105,454 | 28,830 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,786,015 | 28,645 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,702,320 | 28,770 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,969,519 | 29,475 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,851,729 | 29,332 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,824,302 | 29,410 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,961,474 | 32,534 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,862,313 | 31,672 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,744,216 | 31,292 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||